Insider · CIK 0002033333
Kelly Gold
Files at XFOR (X4 Pharmaceuticals, Inc), CAMP (Camp4 Therapeutics Corp). First filing Sep 11, 2025, latest Sep 2, 2026.
In brief
Kelly Gold files SEC Form 4 as CFO and director at CAMP (Camp4 Therapeutics Corp), and also at XFOR (X4 Pharmaceuticals, Inc). Since Sep 11, 2025, Kelly Gold has reported 3 open-market buys worth $60k and 0 open-market sells worth $0, the latest filed on Sep 2, 2026.
A track record needs three past buys with six months of prices behind them; Kelly Gold has 1, so none is measured yet.
The newest scored trade: bought $40k of CAMP on Aug 31, 2026, filed Sep 2, 2026, scored 44 (moderate). In the last 12 months: 2 buys worth $50k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CAMP: Camp4 Therapeutics Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | CAMPbuy Camp4 Therapeutics Corp | $40k 10,000 shares | - | +181% from low-44% from high | |
| 48Moderate | Camp4 Therapeutics Corp | $11k 6,551 shares | +10% | +210% from low-41% from high | |
| 48Moderate | Camp4 Therapeutics Corp | $9,999 6,060 shares | +10% | +106% from low-76% from high |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | CAMP Camp4 Therapeutics Corp | POpen-market purchase Common Stockindirect: By Spouse | +10,000 | $3.96 | $40k | 10,000 | 42 d ago |
| Aug 3, 2026 | CAMP Camp4 Therapeutics Corp | POpen-market purchase Common Stock | +6,551 | $1.65 | $11k | 74,428 | Aug 5, 2026 |
| Jul 1, 2026 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Stock Option (right to buy)derivative | +110,000 | $0.00 | $0 | 110,000 | Jul 1, 2026 |
| Apr 1, 2026 | CAMP Camp4 Therapeutics Corp | AGrant or award Stock Option (Right to Buy)derivative | +215,000 | $0.00 | $0 | 215,000 | Apr 3, 2026 |
| Dec 11, 2025 | CAMP Camp4 Therapeutics Corp | AGrant or award Stock Option (Right to Buy)derivative | +190,000 | $0.00 | $0 | 190,000 | Dec 22, 2025 |
| Sep 11, 2025 | CAMP Camp4 Therapeutics Corp | POpen-market purchase Common Stock | +6,060 | $1.65 | $9,999 | 67,877 | Sep 11, 2025 |
| Apr 1, 2025 | CAMP Camp4 Therapeutics Corp | AGrant or award Stock Option (Right to Buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Apr 3, 2025 |
Questions about Kelly Gold
Answered from the filings on this page, as of the latest one.
Is Kelly Gold buying or selling?
In the last 12 months Kelly Gold reported 2 open-market buys worth $50k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $40k of CAMP on Aug 31, 2026. Grants, option exercises and tax withholding are not counted.
How did Kelly Gold's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kelly Gold has 1.
Where does Kelly Gold file Form 4?
Kelly Gold has filed Form 4 at CAMP (Camp4 Therapeutics Corp) as Chief Financial Officer; XFOR (X4 Pharmaceuticals, Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.